HASELTINE, ERIC L.,MOSKOWITZ, SAMUEL,ROBERTSON, SARAH,WALTZ, DAVID,CHEN, WEICHAO GEORGE
申请号：
CA3069226
公开号：
CA3069226A1
申请日:
2018.07.17
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Compound I of the formula (I) and/or pharmaceutically acceptable salt(s) of Compound I comprised in a pharmaceutical composition and methods of using the same to treat cystic fibrosis.
